
Answers from every biopsy
QuantumCyte is a Fremont, California-based biotechnology company pioneering next-generation automated microdissection pathology through its Cytomask platform. The company combines patented science and technology to link digital pathology with molecular analysis, enabling high-precision tissue analysis from biopsy samples. QuantumCyte has collaborated with Roche on molecular pathology applications for precision medicine.
Create a free account to see funding visualizations and detailed round data.
Create Free AccountCreate a free account to see full funding history, valuations, and investor participation.
Create Free AccountCreate a free account to see which investors have funded this company.
Create Free Account